Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > After hours beating.

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Mar 23, 2022 8:11am

90 Views

Post# 34536929

RE:After hours beating.

I find CNBC's app gives the most accurate report on after hours trading. Other apps seem to capture dubious trades and CNBC filters those out. I half wonder if those other apps contain fictitious trades meant to influence retail investors. It is probably something the SEC should look into. CNBC's app reported no trading post market yesterday or pre-market so far today.